COMMUNIQUÉ DE PRESSE
par Organicell Regenerative Medicine, Inc.
OTCMKTS : $OCEL ð Organicell Activates COPD Trial at Mayo Clinic!
EQS-News: Organicell Regenerative Medicine, Inc.
OTCMKTS : $OCEL ð Organicell Activates COPD Trial at Mayo Clinic!
16.11.2022 / 19:20 CET/CEST
The issuer is solely responsible for the content of this announcement.
16.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Organicell Regenerative Medicine, Inc. |
| United States | |
| ISIN: | US68621D1072 |
| EQS News ID: | 1489793 |
| End of News | EQS News Service |
1489793 16.11.2022 CET/CEST
